Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Observational Cohort Study of Participants at Risk for Chronic Graft-Versus-Host Disease in the United States (THRIVE)

NCT05919511 is registered in ClinicalTrials.gov with Incyte Corporation as lead sponsor.

NCT NCT05919511
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05919511 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Observational Cohort Study of Participants at Risk for Chronic Graft-Versus-Host Disease in the United States (THRIVE)
Lead sponsor
Incyte Corporation
Phase
Observational
Overall status
Recruiting
Start date
August 1, 2023
Completion date
October 15, 2027
Enrollment
1,500 (estimated)
Sites
37

Conditions

As the registry lists them; a condition with its own page is linked.

cgvhd